Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation (original ) (raw )Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
Attilio Bondanza
New England Journal of Medicine, 2009
View PDFchevron_right
Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors
Ryuji Tanosaki
British Journal of Haematology, 2005
View PDFchevron_right
HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism
Hiroh Saji
Blood, 2009
View PDFchevron_right
The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia
Tarek Ben Othman
Bone Marrow Transplantation, 2001
View PDFchevron_right
Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI
I. Jollet
Bone marrow transplantation, 2016
View PDFchevron_right
HLA-mismatched microtransplantation for relapsed or refractory acute myeloid leukemia as a bridge to allogeneic hematopoietic stem cell transplantation
Neeraj Sidharthan
Bone Marrow Transplantation, 2019
View PDFchevron_right
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning …
Richard Maziarz
Biology of Blood and …, 2008
View PDFchevron_right
Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match
Arturo Molina , Koen van Besien
Biology of Blood and Marrow Transplantation, 2008
View PDFchevron_right
Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation
Jacek Nowak
HLA, 2018
View PDFchevron_right
Clinical Significance of HLA-E*0103 Homozygosity on Survival After Allogeneic Hematopoietic Stem-Cell Transplantation
Johannes Pröll
Transplantation, 2009
View PDFchevron_right
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
Paula Muñiz
Frontiers in Immunology, 2021
View PDFchevron_right
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
mauro marchesi
Blood, 2014
View PDFchevron_right
Bone Marrow Transplantation for Chronic Myeloid Leukemia With Volunteer Unrelated Donors Using Ex Vivo or In Vivo T-cell Depletion: Major Prognostic Impact of HLA Class I Identity Between Donor and Recipient
Richard Szydlo
1995
View PDFchevron_right
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants
ISABEL Cunningham
Blood, 1989
View PDFchevron_right
HLA Disparity and Rapid Immune Reconstitution Do Not Overcome Propensity to Relapse in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant (HSCT) With Persistent Disease at the Time of Transplant
Onder Alpdogan
Biology of Blood and Marrow Transplantation, 2011
View PDFchevron_right
Transplantation in Remission Improves the Disease-Free Survival of Patients with Advanced Myelodysplastic Syndromes Treated with Myeloablative T Cell-Depleted Stem Cell Transplants from HLA-Identical Siblings
Nancy Kernan
Biology of Blood and Marrow Transplantation, 2008
View PDFchevron_right
HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research
Marcelo A Fernandez-vina
Biology of Blood and Marrow Transplantation, 2015
View PDFchevron_right
Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci
Borje Andersson
Biology of Blood and Marrow Transplantation, 2011
View PDFchevron_right
Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated Donor
Hidetoshi Inoko , Hiroh Saji
Biology of Blood and Marrow Transplantation, 2007
View PDFchevron_right
Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia
Nathan Punwani
Leukemia Research Reports
View PDFchevron_right
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
Hakan Ozdogu
HAL (Le Centre pour la Communication Scientifique Directe), 2017
View PDFchevron_right
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning
R. Hough
Blood, 2010
View PDFchevron_right
Novel strategies for adoptive therapy following HLA disparate transplants
Aisha Hasan
Best Practice & Research Clinical Haematology, 2011
View PDFchevron_right
Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS
Parastoo Dahi
Bone Marrow Transplantation, 2016
View PDFchevron_right
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation
Kirk Schultz
Blood, 2014
View PDFchevron_right
HLA-Haploidentical Transplantation with Regulatory and Conventional T-Cells Adoptive Immunotherapy in Pediatric Patients with High-Risk Acute Leukemia
mauro marchesi
Transplantation and Cellular Therapy, 2021
View PDFchevron_right
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities
Philip Rowlings
Blood, 2000
View PDFchevron_right
Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab
Kate Matthews
British Journal of Haematology, 2010
View PDFchevron_right
The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party
Pavel Jindra
Journal of Hematology & Oncology, 2016
View PDFchevron_right
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
Michael Maris
Blood, 2003
View PDFchevron_right
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT …
Antonin Vitek
Leukemia, 2010
View PDFchevron_right
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
Brenda Sandmaier
Biology of Blood and Marrow Transplantation, 2008
View PDFchevron_right
Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
John Wingard
Journal of Clinical Oncology, 2012
View PDFchevron_right
HLA Association with Hematopoietic Stem Cell Transplantation Outcome: The Number of Mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 Is Strongly Associated with Overall Survival
Dominique Charron , A. Toubert , Pascale Perrier
Biology of Blood and Marrow Transplantation, 2007
View PDFchevron_right